Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT02192112 · ClinicalTrials.gov registry record
Advanced XLIF Monitoring Pilot Study
A clinical trial of Degenerative Lumbar Disc Disease, sponsored by NuVasive.
- Completed
- Registry status
- 57
- Enrollment target
- 2
- Study locations
NCT02192112: Completed study of Degenerative Lumbar Disc Disease, sponsored by NuVasive.
NCT02192112 is a study of Degenerative Lumbar Disc Disease that has completed, run by NuVasive. The registered enrollment target is 57 participants. The trial reports 2 study locations across 2 states. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT02192112, a study of Degenerative Lumbar Disc Disease, has completed, sponsored by NuVasive.
- COMPLETED
- Registry status
- 57 participants
- Enrollment target
- 2
- Study locations
Study Summary
Though the utility of NVM5 neuromonitoring by stimulating within the surgical site during XLIF has been demonstrated, it is hypothesized that more information may be gathered if a greater section of the motor neural pathway was monitored (i.e., stimulation above the surgical site and recording the subsequent muscle response in the lower limbs). Currently, there has not been demonstrated a practical method of stimulating the lumbosacral nerve roots locally, but well-above the surgical site in this fashion. This protocol is intended to evaluate the feasibility and reproducibility of using surface stimulation and return (anode) electrodes to stimulate the lumbosacral nerve roots, and record responses from the relevant innervated muscle groups of the lower limbs.
Conditions Studied
Study Locations (2)
Colorado
- Durango Orthopaedics Associates/Spine Colorado - Durango
Georgia
- Pinnacle Orthopaedics & Sports Medicine Specialists - Marrietta
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 57 participants |
| Start Date | 2014-06 |
| Est. Completion | 2018-05-08 |
What the finished NCT02192112 record still lists
NCT02192112 is an observational study that tracks outcomes without assigning an intervention. The registry caps enrollment at 57 participants, a relatively small participant target.
The record links to 1 condition, with Degenerative Lumbar Disc Disease appearing as the primary indexed condition, and to 0 interventions.
NCT02192112 reports a single indexed study location in Colorado, Georgia.
Frequently Asked Questions
What is clinical trial NCT02192112 about?
NCT02192112 is a clinical study titled "Advanced XLIF Monitoring Pilot Study". Though the utility of NVM5 neuromonitoring by stimulating within the surgical site during XLIF has been demonstrated, it is hypothesized that more information may be gathered if a greater section of the motor neural pathway was monitored (i.e., stimulation above the surgical site and recording the s...
What is the current status of trial NCT02192112?
This trial is currently completed. The enrollment target is 57 participants. The study started on 2014-06. Estimated completion is 2018-05-08.
What conditions does trial NCT02192112 study?
This clinical trial studies the following conditions: Degenerative Lumbar Disc Disease.
Who is sponsoring clinical trial NCT02192112?
This trial is sponsored by NuVasive, which has 28 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT02192112 being conducted?
This trial has 2 study locations across Colorado, Georgia. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Degenerative Lumbar Disc Disease
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT03521830 · 57 participants · Phase 2
Nivolumab Alone or Plus Relatlimab or Ipilimumab for Patients With Locally-Advanced Unresectable or Metastatic Basal Cell Carcinoma
- NCT03587701 · 57 participants · Phase 2
Effects of Anakinra in Subjects With Corticosteroid-resistant/Intolerant Meniere's Disease and Autoimmune Inner Ear Disease
- NCT04104126 · 57 participants · NA
Blood Flow Restriction Therapy in Achilles Injury
- NCT04703842 · 57 participants · Phase 1
Modulation of SERCA2a of Intra-myocytic Calcium Trafficking in Heart Failure With Reduced Ejection Fraction
Similar registry start date
- NCT05988463 · started 2027-01-01 · Phase 1
Dose-Escalation Study of Artesunate Patients With IPF
- NCT07219706 · started 2026-12-10 · NA
Dietary Fiber and Time Restricted Eating
- NCT02831335 · started 2026-12-01
Technical Development of Multi-Parametric Renocerebral MRI
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia